Table 2.
Indications for Computed Tomography Imaging in Conventional and Split-bolus groups
| Indication | Conventional Group N (%) |
Split-Bolus Group N (%) |
|---|---|---|
| Lung cancer | 54 (52.9) | 50 (50.0) |
| Clinical/radiologic suspicion | 22 (21.6) | 22 (22.0) |
| Staging/Follow-up | 32 (31.4) | 28 (28.0) |
| Malignant mesothelioma | 4 (0.04) | 2 (2.0) |
| Clinical/radiologic suspicion | 3 (0.03) | 2 (2.0) |
| Follow-up | 1 (0.01) | - |
| Other primary malignancies | ||
| Follow-up | 15 (0.15) | 32 (32.0) |
| Tuberculosis | 4 (0.04) | 1 (1.0) |
| Sarcoidosis | 2 (0.02) | 4 (4.0) |
| Thymoma | 4 (0.04) | 0 |
| Bacterial/fungal infection | 1 (0.01) | 2 (2.0) |
| Miscellaneous | 18 (17.6) | 9 (9.0) |